Relypsa

About:

Relypsa is a biopharmaceutical company developing drugs for treating cardiovascular and renal diseases.

Top Investors: OrbiMed, Silicon Valley Bank, 5AM Ventures, New Leaf Venture Partners, Athyrium Capital Management LP

Description:

Relypsa is a biotech company. They discover and develop non-absorbed polymeric drugs for applications in cardiovascular and renal diseases. They specialize in iron deficiency, nephrology, and cardio-renal therapies.

Total Funding Amount:

$669M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Redwood City, California, United States

Founded Date:

2007-10-01

Contact Email:

PR(AT)Relypsa.com

Founders:

Gerrit Klaerner

Number of Employees:

251-500

Last Funding Date:

2016-05-03

IPO Status:

Delisted

Industries:

Biopharma

Biotechnology

Health Care